staurosporine has been researched along with Acute Kidney Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; He, Q; Jiang, L; Luo, J; Wen, P; Xie, W; Xu, X; Yang, J; Zhang, Y; Zhou, Y | 1 |
| Daver, NG; Glass, WF; Kala, J; Pankow, JD; Richard-Carpentier, G | 1 |
2 other study(ies) available for staurosporine and Acute Kidney Injury
| Article | Year |
|---|---|
Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury.
Topics: Acute Kidney Injury; Cisplatin; Homeostasis; Humans; Mitochondria; Pyruvate Kinase; Staurosporine | 2023 |
Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin.
Topics: Acute Kidney Injury; Administration, Intravenous; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Combined Modality Therapy; Cyclophosphamide; Glomerulonephritis; Glucocorticoids; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung Diseases; Methylprednisolone; Middle Aged; Necrosis; Plasma Exchange; Protein Kinase Inhibitors; Renal Dialysis; Staurosporine; Treatment Outcome | 2020 |